Historical record - last NADAC publication: 3/23/2016

Product Information

EPIVIR 10 MG/ML ORAL SOLN is a brand product labeled by ViiV Healthcare Company, priced at $0.4452 per ML under NDC 49702020548. Its NADAC has been published 177 times since Nov 28, 2013.

The High Outlier badge above means this manufacturer's average price in the lamivudine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

EPIVIR 10 MG/ML ORAL SOLN

lamivudine
$0.4452per ML
High Outlier

Strength

10 mg/mL

NDC

49702020548

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

3/23/2016

Active Ingredients

LAMIVUDINE

Approval Type

New Drug (NDA)

FDA Application

NDA020596

On Market Since

10/4/2010

Price Statistics

The NADAC for EPIVIR 10 MG/ML ORAL SOLN has been published 177 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$0.4452 per ML
All-time high$0.4557 (Dec 10, 2014)
All-time low$0.4429 (Jan 21, 2015)
Median price$0.4452
Average price$0.4476
Largest weekly change+2.5% (Aug 20, 2014)
Weeks tracked177
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+0.4%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lamivudine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of EPIVIR 10 MG/ML ORAL SOLN?

The current National Average Drug Acquisition Cost (NADAC) for EPIVIR 10 MG/ML ORAL SOLN, manufactured by ViiV Healthcare Company, is $0.4452 per ML (NDC 49702020548), effective Apr 12, 2017.

How has the price of EPIVIR 10 MG/ML ORAL SOLN changed over time?

Over the history we have for it, the NADAC for EPIVIR 10 MG/ML ORAL SOLN has held within roughly two percent of its current level. It has been tracked across 177 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for EPIVIR 10 MG/ML ORAL SOLN?

Since Nov 28, 2013, the NADAC for EPIVIR 10 MG/ML ORAL SOLN has ranged from a low of $0.4429 (Jan 21, 2015) to a high of $0.4557 (Dec 10, 2014), with a median of $0.4452 per ML.

Are there cheaper alternatives to EPIVIR 10 MG/ML ORAL SOLN?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of EPIVIR 10 MG/ML ORAL SOLN, so no direct lower-cost alternative is listed.

Who manufactures EPIVIR 10 MG/ML ORAL SOLN?

EPIVIR 10 MG/ML ORAL SOLN (NDC 49702020548) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.